Multiple Assemblies exist for SMTL entry 8cqe
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-Fluorocyclopropane-1-carboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(2-methyl-4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide (Compound 37); X-RAY DIFFRACTION 2.85 Å

	SMTL ID 8cqe.1 Ligands (2~{S},4~{R})-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[(1~{S})-7-fluoranyl-6-(4-methyl-1,3-thiazol-5-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-oxidanyl-pyrrolidine-2-carboxamide Polypeptides Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 8cqe.2 Ligands (2~{S},4~{R})-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[(1~{S})-7-fluoranyl-6-(4-methyl-1,3-thiazol-5-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-oxidanyl-pyrrolidine-2-carboxamide Polypeptides Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 8cqe.3 Ligands (2~{S},4~{R})-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[(1~{S})-7-fluoranyl-6-(4-methyl-1,3-thiazol-5-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-oxidanyl-pyrrolidine-2-carboxamide Polypeptides Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 8cqe.4 Ligands (2~{S},4~{R})-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[(1~{S})-7-fluoranyl-6-(4-methyl-1,3-thiazol-5-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-oxidanyl-pyrrolidine-2-carboxamide Polypeptides Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer